FT HEALTH INNOVATIONS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2023
Company Registration No. SC738139 (Scotland)
PAGES FOR FILING WITH REGISTRAR
FT HEALTH INNOVATIONS LTD
COMPANY INFORMATION
Directors
Dr J N F Taljard
(Appointed 12 July 2022)
Mr M J Taljard
(Appointed 12 July 2022)
Ms K I Taljard
(Appointed 12 July 2022)
Dr L M Taljard
(Appointed 12 July 2022)
Company number
SC738139
Registered office
William Duncan + Co
Chartered Accountants
44 Bank Street
Kilmarnock
KA1 1HA
Accountants
William Duncan + Co
44 Bank Street
Kilmarnock
Ayrshire
United Kingdom
KA1 1HA
FT HEALTH INNOVATIONS LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
FT HEALTH INNOVATIONS LTD
BALANCE SHEET
- 1 -
2023
Notes
£
£
Current assets
Cash at bank and in hand
89
Creditors: amounts falling due within one year
3
(1,898)
Net current liabilities
(1,809)
Capital and reserves
Called up share capital
4
100
Profit and loss reserves
(1,909)
Total equity
(1,809)
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial period ended 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 10 April 2024 and are signed on its behalf by:
Dr J N F Taljard
Director
Company registration number SC738139 (Scotland)
FT HEALTH INNOVATIONS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2023
- 2 -
1
Accounting policies
Company information
FT Health Innovations Ltd is a private company limited by shares incorporated in Scotland. The registered office is William Duncan + Co, Chartered Accountants, 44 Bank Street, Kilmarnock, KA1 1HA.
1.1
Reporting period
The financial statements have been prepared covering the period from incorporation on 12 July 2022 to the period end date of 31 July 2023.
1.2
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The company has a net deficit on the balance sheet of £1,809. However the directors consider that the going concern basis of preparation is appropriate due to the continued support of the holding company, JNFT Holdings.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.3
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.4
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
1.5
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
FT HEALTH INNOVATIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 JULY 2023
- 3 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2023
Number
Total
3
Creditors: amounts falling due within one year
2023
£
Trade creditors
17
Amounts owed to group undertakings
200
Other creditors
1,681
1,898
4
Called up share capital
2023
2023
Ordinary share capital
Number
£
Issued and fully paid
Ordinary shares of £1 each
100
100
5
Directors' transactions
Description
% Rate
Opening balance
Amounts repaid
Closing balance
£
£
£
Directors loan
-
-
(330)
(330)
-
(330)
(330)